Home Spring Mountains in Sight: 2023 Future Healthcare Equity Investment Forum Unveils Agenda

Spring Mountains in Sight: 2023 Future Healthcare Equity Investment Forum Unveils Agenda

Oct 30, 2023 10:49 CST Updated 10:49

画板 24(1).png

Opportunities and challenges always coexist, as is evident in the current state of equity investment in the primary healthcare market. Although the number and volume of institutional investments have tightened, enthusiasm for corporate financing has waned, and enterprise valuations have shrunk, new rounds of changes have accelerated the adjustment and adaptation of equity investment in the primary healthcare market. Investment institutions are delving deeper into early-stage and small-scale investments; innovative niche sectors such as AICG+ healthcare and brain science have become hot topics in the medical industry.


How will the innovation and investment landscapes of the future healthcare industry evolve? In a complex macroeconomic environment, how can investment institutions and enterprises break through existing constraints? Which emerging sectors in healthcare are currently flourishing, and which new technologies have achieved breakthrough applications? Through this forum, we aim to gain insights into the development of the healthcare finance industry, promote deep integration between industry and finance, empower new tracks in medical infrastructure, foster a collaborative investment ecosystem, and drive the advancement of China’s healthcare industry.


On November 18, 2023, VB100 will meet you in Beijing and invites you to participate.2023 Future Healthcare Equity Investment Forum & The 5th Future Healthcare Fund Partners (LP-GP) Summit.Themed “Hopeful Horizons,” this forum features over 20 distinguished guests, eight key projects, and more than 300 industry participants. It connects leading healthcare limited partners (LPs) and general partners (GPs) to jointly explore market trends amid the new economic landscape and engage in dialogue on cutting-edge investment philosophies and logic.


免费.png

Scan the QR Code to Claim Your Free Ticket

(Limited free tickets available while supplies last)


Ticket Benefits:

1. One ticket for the 2023 Future Healthcare Equity Investment Forum

2. On-site Forum Liaison Group

3. Guest Authorization for Post-Conference Video Playback


Forum Agenda

LPGP议程_Sheet1.jpg

Forum Overview


画板 24.png


Organizer

VB100, VCBeat, VCBeat

Co-Hosted by

Changfa Zhan

Conference Time

November 18

Conference Venue

Lecture Hall, 1st Floor, Taikang Training Institute, Changping, Beijing

Taikang Academy

No. 12 Shengmingyuan Road, Zhongguancun Life Science Park, Changping District, Beijing


01
Gathering Investment Leaders to Explore Industry Opportunities


The previous forum (the 4th Future Healthcare Fund Partners Summit) invited over 20 distinguished guests to share insights, featured roadshows by four outstanding projects, and attracted more than 200 engaged attendees. Centered on the themes of “Recognizing Change” and “Adapting to Change,” and examining transformations at three levels—global, national (China), and industrial—the event extensively connected healthcare fund partners worldwide to explore how seizing investment opportunities can create greater value in the healthcare sector.


VCBeatVB100 is fully preparing for the 2023 Future Healthcare Equity Investment Forum and the 5th Future Healthcare Fund Partners (LP-GP) Summit.Anchored in the primary equity investment ecosystem of the healthcare and medical sectors, the forum will extensively connect with leading figures in healthcare equity investment, gathering over 300 high-quality Limited Partners (LPs) and trillions in investable capital to share the latest market dynamics and cutting-edge insights. Building on the foundation of the previous four Healthcare Fund Partner Summits, the event will incorporate award selections and pitch sessions, fostering richer interactive exchanges, more diverse discussion topics, and a more open conference ecosystem. It will delve deeply into value creation and value investment in the global healthcare industry’s capital markets, while reviewing the past and envisioning the future of global healthcare investment.


02
Precision Research,
Exploring Innovation, Investment, and Sustainable Health


Under the new landscape, the equity investment industry is undergoing significant transformation. For private equity firms in the primary healthcare market, enduring the volatility of capital markets, maintaining agile responses to the sector’s latent potential for sudden growth, and strategizing how to create greater value and opportunities through investment and strategic partnerships are essential conditions for long-term sustainability. The topics discussed at this forum are derived from VB100’s industrial research. We will examine the impact of global health challenges on the healthcare sector and how investment can empower solutions to these challenges; explore opportunities in investing in sustainable healthcare solutions, including health sustainability and corporate social responsibility; and discuss how emerging technologies are reshaping healthcare, which innovative projects in specific sub-sectors will stand out, and how to integrate investment with innovation to drive new value creation and growth. Led by distinguished guests, all attendees will jointly explore value growth, innovative investment, and sustainable health within a global context.


03
SelectionBenchmark Cases,Most Popular Investment Institutions Among Enterprises


As the year draws to a close, the VB100 Awards Committee will leverage the 2023 Future Healthcare Equity Investment Forum to innovate upon the existing “Top 100” framework—specifically the Pengcheng Awards for investment institutions—by launching a new evaluation program focused on equity investments in healthcare. This initiative will conduct a one-month call for submissions and research campaign targeting equity investment firms that invest in, serve, and empower the high-quality development of China’s domestic healthcare industry. Based on detailed, vivid, and specific primary research data, the program will select the most representative cases of the year in investment, exit, and empowerment strategies. Concurrently, the “2023 Top 10 Investment Institutions Most Preferred by Innovative Healthcare Companies” selection will be carried out. The awards ceremony will take place during the forum, where representatives from leading institutions will gather to discuss hot investment topics and explore fundraising and collaboration opportunities.


● How to Participate in Case Selection

1. Download the survey form, complete and verify the information (once submitted, no modifications will be accepted; if there are errors in the submitted information, you may resubmit during the survey period, and the organizing committee will refer to the latest version of the survey data)

下载调研表.png


 Download the survey form link:https://qr18.cn/FtQEUd


2. Submit the survey via the online submission portal (email submissions are not accepted). Scan the QR code below or copy the link below into your browser to access the portal and complete the survey submission.

上传调研表.png

 Upload Survey Form:https://vb100.mike-x.com/jZwiU



● Participation“Top 10 Investment Institutions Most Welcomed by Innovative Enterprises in Future Healthcare 2023” Voting Event

投票.png

(Scan the QR code to vote for your favorite investment firms)



● In-Depth Research and Inquiry

VB100 - Ms. Li 18428384021 (WeChat ID same)

VB100 - Ms. Wu 15696132719 (WeChat ID same)



04
Focusing on Four Major Tracks: High-Quality Projects Public Roadshow


This roadshow focuses on four key sectors: pharmaceuticals and biotechnology, advanced intelligent manufacturing and medical devices, upstream pharmaceutical and device supply chain services, and early-stage innovation with technology transfer., featuring a curated selection of 20 innovative healthcare projects. Leveraging the summit’s access to top-tier investors, the roadshow will extend targeted invitations to at least 10 leading professional investment experts to provide in-depth commentary and diagnostic assessments of the presented projects. Additionally, an open call for interactive panelists will be issued to all investment institutions, with at least 40 selected investment professionals participating in on-site interactive discussions during the roadshow. CurrentlyJingchuang High-Dimension, Yuanjing Taike, Weiner Anke, Zhida Pharmaceutical, Knowledge Matrix, Shudan Medical, and six other companiesConfirmed to conduct the roadshow at this VBO roadshow session.

Roadshow Project Materials:https://mp.weixin.qq.com/s/Pv1QtZ7Btf1so3l9ndudzQ


Project Application, Commentary Guest ParticipationChannel:

路演.png

https://vb100.mike-x.com/2VNmr


Register for the Conference


免费.png

Scan the QR Code to Register


- Share for a Chance to Win -

To express our gratitude for your enthusiastic support of this event, from today onward, you can receive a collection of the VBInsight Monthly Reports on Investment and Financing from January to August 2023 by sharing this article on your WeChat Moments.

Event Rules:Share this article to your WeChat Moments, without setting group visibility restrictions. Caption:Resilience Era, Value Growth: Registration Now Open for the 2023 Future Healthcare Equity Investment Forum!Keep the post on your WeChat Moments for more than 24 hours, upload a screenshot of the post to the form, and upon approval, the report collection will be sent via email.

 

转发福利.png


- Contact Us -


联系我们.png